Latham & Watkins LLP represented Syzygy Plasmonics in the transaction.Syzygy Plasmonics has announced a US$23 million Series B financing led by Horizons Ventures with participation from new…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
